SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    D. Hoelzer, R. Bassan, H. Dombret, A. Fielding, J. M. Ribera, C. Buske, Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, 2016, mdw025

    CrossRef

  2. 2
    Omar Al Ustwani, Neha Gupta, Hatoon Bakhribah, Elizabeth Griffiths, Eunice Wang, Meir Wetzler, Clinical updates in adult acute lymphoblastic leukemia, Critical Reviews in Oncology/Hematology, 2016, 99, 189

    CrossRef

  3. 3
    Craig Speziali, Kristjan Paulson, Matthew Seftel, Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults, Current Hematologic Malignancy Reports, 2016,

    CrossRef

  4. 4
    Farhad Ravandi, Jeffrey L. Jorgensen, Susan M. O'Brien, Elias Jabbour, Deborah A. Thomas, Gautam Borthakur, Rebecca Garris, Xuelin Huang, Guillermo Garcia-Manero, Jan A. Burger, Alessandra Ferrajoli, William Wierda, Tapan Kadia, Nitin Jain, Sa A. Wang, Sergei Konoplev, Partow Kebriaei, Richard E. Champlin, Deborah McCue, Zeev Estrov, Jorge E. Cortes, Hagop M. Kantarjian, Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia, British Journal of Haematology, 2016, 172, 3
  5. 5
    Nicholas J. Short, Hagop M. Kantarjian, Elias J. Jabbour, Susan M. O'Brien, Stefan Faderl, Jan A. Burger, Rebecca Garris, Wei Qiao, Xuelin Huang, Nitin Jain, Marina Konopleva, Tapan M. Kadia, Naval Daver, Gautam Borthakur, Jorge E. Cortes, Farhad Ravandi, Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia, American Journal of Hematology, 2016, 91, 4
  6. 6
    Satoshi Hirase, Daiichiro Hasegawa, Hironobu Takahashi, Kensuke Moriwaki, Atsuro Saito, Aiko Kozaki, Toshiaki Ishida, Tomoko Yanai, Keiichiro Kawasaki, Nobuyuki Yamamoto, Ikuko Kubokawa, Takeshi Mori, Akira Hayakawa, Noriyuki Nishimura, Hisahide Nishio, Kazumoto Iijima, Yoshiyuki Kosaka, Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia, International Journal of Hematology, 2015, 102, 5, 594

    CrossRef

  7. 7
    E. Curran, W. Stock, How I treat acute lymphoblastic leukemia in older adolescents and young adults, Blood, 2015, 125, 24, 3702

    CrossRef

  8. 8
    Chantal Fossat, Mikael Roussel, Isabelle Arnoux, Vahid Asnafi, Chantal Brouzes, Francine Garnache-Ottou, Marie-Christine Jacob, Emilienne Kuhlein, Elizabeth Macintyre-Davi, Adriana Plesa, Nelly Robillard, Jean Tkaczuk, Norbert Ifrah, Herve Dombret, Marie C. Béné, Andre Baruchel, Richard Garand, Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A french multicenter study, Cytometry Part B: Clinical Cytometry, 2015, 88, 1
  9. 9
    N. Dhedin, A. Huynh, S. Maury, R. Tabrizi, K. Beldjord, V. Asnafi, X. Thomas, P. Chevallier, S. Nguyen, V. Coiteux, J.-H. Bourhis, Y. Hichri, M. Escoffre-Barbe, O. Reman, C. Graux, Y. Chalandon, D. Blaise, U. Schanz, V. Lheritier, J.-Y. Cahn, H. Dombret, N. Ifrah, Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia, Blood, 2015, 125, 16, 2486

    CrossRef

  10. 10
    Emma Bergfelt, Piotr Kozlowski, Lucia Ahlberg, Erik Hulegårdh, Hans Hägglund, Karin Karlsson, Alicja Markuszewska-Kuczymska, Beata Tomaszewska-Toporska, Bengt Smedmyr, Maria Åström, Rose-Marie Amini, Heléne Hallböök, Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study, Medical Oncology, 2015, 32, 4

    CrossRef

  11. 11
    Elisabeth Paietta, Should minimal residual disease guide therapy in AML?, Best Practice & Research Clinical Haematology, 2015, 28, 2-3, 98

    CrossRef

  12. 12
    Naresh Bumma, Nikolaos Papadantonakis, Anjali S Advani, Structure, development, preclinical and clinical efficacy of blinatumomab in acute lymphoblastic leukemia, Future Oncology, 2015, 11, 12, 1729

    CrossRef

  13. 13
    Bakul I. Dalal, Areej Al Mugairi, Steven Pi, Soo Yeon Lee, Nikisha S. Khare, Jason Pal, Adam Bryant, Alok P. Vakil, Sally Lau, Yasser R. Abou Mourad, Aberrant Expression of CD13 Identifies a Subgroup of Standard-Risk Adult Acute Lymphoblastic Leukemia With Inferior Survival, Clinical Lymphoma Myeloma and Leukemia, 2014, 14, 3, 239

    CrossRef

  14. 14
    David I. Marks, Laura Alonso, Rohini Radia, Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia, Hematology/Oncology Clinics of North America, 2014, 28, 6, 995

    CrossRef

  15. 15
    Amin Ben Lassoued, Vanessa Nivaggioni, Jean Gabert, Minimal residual disease testing in hematologic malignancies and solid cancer, Expert Review of Molecular Diagnostics, 2014, 14, 6, 699

    CrossRef

  16. 16
    B. Patel, A. Dey, A. Z. Castleton, C. Schwab, E. Samuel, J. Sivakumaran, B. Beaton, N. Zareian, C. Y. Zhang, L. Rai, T. Enver, A. V. Moorman, A. K. Fielding, Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology, Blood, 2014, 124, 1, 96

    CrossRef

  17. 17
    K. Beldjord, S. Chevret, V. Asnafi, F. Huguet, M.-L. Boulland, T. Leguay, X. Thomas, J.-M. Cayuela, N. Grardel, Y. Chalandon, N. Boissel, B. Schaefer, E. Delabesse, H. Cave, P. Chevallier, A. Buzyn, T. Fest, O. Reman, J.-P. Vernant, V. Lheritier, M. C. Bene, M. Lafage, E. Macintyre, N. Ifrah, H. Dombret, Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia, Blood, 2014, 123, 24, 3739

    CrossRef

  18. 18
    G Kunter, J B Perkins, J Pidala, T Nishihori, M A Kharfan-Dabaja, T Field, H Fernandez, L Perez, F Locke, E Ayala, M Tomblyn, J L Ochoa-Bayona, B Betts, M Nieder, C Anasetti, Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission, Bone Marrow Transplantation, 2014, 49, 1, 11

    CrossRef

  19. 19
    Orietta Spinelli, Manuela Tosi, Marie Lorena Guinea Montalvo, Barbara Peruta, Margherita Parolini, Anna Maria Scattolin, Elena Maino, Piera Viero, Alessandro Rambaldi, Renato Bassan, Prognostic impact of minimal residual disease in adult acute lymphoblastic leukemia, International Journal of Hematologic Oncology, 2014, 3, 6, 419

    CrossRef

  20. 20
    Ju Bai, Aili He, Chen Huang, Juan Yang, Wanggang Zhang, Jianli Wang, Yun Yang, Pengyu Zhang, Yang Zhang, Fuling Zhou, Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia, Proteome Science, 2014, 12, 1

    CrossRef

  21. 21
    Yi Zhou, Rebecca Slack, Jeffrey L. Jorgensen, Sa A. Wang, Gabriela Rondon, Marcos de Lima, Elizabeth Shpall, Uday Popat, Stefan Ciurea, Amin Alousi, Muzaffar Qazilbash, Chitra Hosing, Susan O'Brien, Deborah Thomas, Hagop Kantarjian, L. Jeffrey Medeiros, Richard E. Champlin, Partow Kebriaei, The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, Clinical Lymphoma Myeloma and Leukemia, 2014, 14, 4, 319

    CrossRef

  22. 22
    Kavita Raj, Acute leukaemia, Medicine, 2013, 41, 5, 269

    CrossRef

  23. 23
    S Nishiwaki, Y Atsuta, J Tanaka, Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?, Bone Marrow Transplantation, 2013, 48, 11, 1369

    CrossRef

  24. 24
    Dario Campana, Wing Leung, Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation, British Journal of Haematology, 2013, 162, 2
  25. 25
    R Garand, K Beldjord, H Cavé, C Fossat, I Arnoux, V Asnafi, Y Bertrand, M-L Boulland, C Brouzes, E Clappier, E Delabesse, T Fest, F Garnache-Ottou, F Huguet, M-C Jacob, E Kuhlein, S Marty-Grès, A Plesa, N Robillard, M Roussel, J Tkaczuk, H Dombret, E Macintyre, N Ifrah, M C Béné, A Baruchel, Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL, Leukemia, 2013, 27, 2, 370

    CrossRef

  26. 26
    S A Buckley, F R Appelbaum, R B Walter, Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia, Bone Marrow Transplantation, 2013, 48, 5, 630

    CrossRef

  27. 27
    A. K. Fielding, G. A. Zakout, Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia, Current Hematologic Malignancy Reports, 2013, 8, 2, 98

    CrossRef

  28. 28
    John O’Reilly, Lisa J. Russell, Julian Cooney, Hannah M. Ensor, Duncan Purtill, Matthew Wright, Anthony V. Moorman, Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia, Pathology, 2013, 45, 6, 609

    CrossRef

  29. 29
    Monika Brüggemann, Nicola Gökbuget, Michael Kneba, Acute Lymphoblastic Leukemia: Monitoring Minimal Residual Disease as a Therapeutic Principle, Seminars in Oncology, 2012, 39, 1, 47

    CrossRef

  30. 30
    Samer K. Khaled, Sandra H. Thomas, Stephen J. Forman, Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults, Current Opinion in Oncology, 2012, 24, 2, 182

    CrossRef

  31. 31
    Satoshi Nishiwaki, Koichi Miyamura, Allogeneic stem cell transplant for adult Philadelphia chromosome-negative acute lymphoblastic leukemia, Leukemia & Lymphoma, 2012, 53, 4, 550

    CrossRef

  32. 32
    J Huang, D-H Zou, Z-J Li, M-W Fu, Y Xu, Y-Z Zhao, J-Y Qi, S-Z Feng, B-C Liu, D Lin, Y-C Mi, M-Z Han, J-X Wang, L-G Qiu, An auto-SCT-based total therapy resulted in encouraging outcomes in adolescents and young adults with acute lymphoblastic leukemia: report from a single center of China, Bone Marrow Transplantation, 2012, 47, 8, 1087

    CrossRef

  33. 33
    M. Bruggemann, T. Raff, M. Kneba, Has MRD monitoring superseded other prognostic factors in adult ALL?, Blood, 2012, 120, 23, 4470

    CrossRef

  34. 34
    Partow Kebriaei, Rima Saliba, Gabriela Rondon, Alexandre Chiattone, Rajyalakshmi Luthra, Paolo Anderlini, Borje Andersson, Elizabeth Shpall, Uday Popat, Roy Jones, Laura Worth, Farhad Ravandi, Deborah Thomas, Susan O’Brien, Hagop Kantarjian, Marcos de Lima, Sergio Giralt, Richard Champlin, Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes, Biology of Blood and Marrow Transplantation, 2012, 18, 4, 584

    CrossRef

  35. 35
    Dario Campana, Elaine Coustan-Smith, Measurements of treatment response in childhood acute leukemia, The Korean Journal of Hematology, 2012, 47, 4, 245

    CrossRef

  36. 36
    D Campana, Minimal residual disease, Leukemia Supplements, 2012, 1, S3

    CrossRef

  37. 37
    Adele K. Fielding, Lalita Banerjee, David I. Marks, Recent Developments in the Management of T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma, Current Hematologic Malignancy Reports, 2012, 7, 2, 160

    CrossRef

  38. 38
    Dario Campana, Should Minimal Residual Disease Monitoring in Acute Lymphoblastic Leukemia be Standard of Care?, Current Hematologic Malignancy Reports, 2012, 7, 2, 170

    CrossRef

  39. 39
    Partow Kebriaei, L. M. Poon, The Role of Allogeneic Hematopoietic Stem Cell Transplantation in the Therapy of Patients with Acute Lymphoblastic Leukemia, Current Hematologic Malignancy Reports, 2012, 7, 2, 144

    CrossRef

  40. 40
    Sujata Narayanan, Paul J. Shami, Treatment of acute lymphoblastic leukemia in adults, Critical Reviews in Oncology/Hematology, 2012, 81, 1, 94

    CrossRef

  41. 41
    Michael J. Burke, Bruce Lindgen, Michael R. Verneris, Treatment of relapsed acute lymphoblastic leukemia: Approaches used by pediatric oncologists and bone marrow transplant physicians, Pediatric Blood & Cancer, 2012, 58, 6
  42. 42
    Veronika Bachanova, Michael J. Burke, Sophia Yohe, Qing Cao, Karamjeet Sandhu, Timothy P. Singleton, Claudio G. Brunstein, John E. Wagner, Michael R. Verneris, Daniel J. Weisdorf, Unrelated Cord Blood Transplantation in Adult and Pediatric Acute Lymphoblastic Leukemia: Effect of Minimal Residual Disease on Relapse and Survival, Biology of Blood and Marrow Transplantation, 2012, 18, 6, 963

    CrossRef

  43. 43
    Josep-Maria Ribera, Advances in acute lymphoblastic leukemia in adults, Current Opinion in Oncology, 2011, 23, 6, 692

    CrossRef

  44. 44
    Adele K. Fielding, Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia, Hematology/Oncology Clinics of North America, 2011, 25, 6, 1255

    CrossRef

  45. 45
    Giovanni Cazzaniga, Maria Grazia Valsecchi, Giuseppe Gaipa, Valentino Conter, Andrea Biondi, Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia, British Journal of Haematology, 2011, 155, 1
  46. 46
    Bella Patel, Aditi Dey, Ehsan Ghorani, Shaji Kumar, Yogeshkumar Malam, Lena Rai, Andrew J Steele, Jennifer Thomson, R Gitendra Wickremasinghe, Yu Zhang, Anna Z Castleton, Adele K Fielding, Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights, Molecular Therapy, 2011, 19, 6, 1034

    CrossRef

  47. 47
    Misato Kikuchi, Junji Tanaka, Takeshi Kondo, Satoshi Hashino, Masaharu Kasai, Mitsutoshi Kurosawa, Hiroshi Iwasaki, Masanobu Morioka, Tsugumichi Kawamura, Nobuo Masauzi, Takashi Fukuhara, Yasutaka Kakinoki, Hajime Kobayashi, Satoshi Noto, Masahiro Asaka, Masahiro Imamura, Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia, International Journal of Hematology, 2010, 92, 3, 481

    CrossRef

  48. 48
    Elaine Coustan-Smith, Dario Campana, Immunologic minimal residual disease detection in acute lymphoblastic leukemia: A comparative approach to molecular testing, Best Practice & Research Clinical Haematology, 2010, 23, 3, 347

    CrossRef

  49. 49
    D. Campana, Minimal Residual Disease in Acute Lymphoblastic Leukemia, Hematology, 2010, 2010, 1, 7

    CrossRef

  50. 50
    Jacob M. Rowe, Prognostic factors in adult acute lymphoblastic leukaemia, British Journal of Haematology, 2010, 150, 4
  51. 51
    D. I. Marks, Treating the "Older" Adult With Acute Lymphoblastic Leukemia, Hematology, 2010, 2010, 1, 13

    CrossRef

  52. 52
    Tsila Zuckerman, Jacob M. Rowe, Leukaemia,
  53. 53
    Merav Bar, Jerald P. Radich, The Detection and Significance of Minimal Residual Disease,